骨保护素

  • 网络Osteoprotegerin;opg;osteoprotegerin OPG;osteoprotegerin,OPG
骨保护素骨保护素
  1. 正常体重的健康成年男性血清瘦素的参考值上限为8.72ng/ml。本组男性血清骨保护素浓度一直是随年龄的增长而增长,70岁之后增长得更快。

    The upper limit of the reference value of serum leptin in normal weight was 8.72ng/ml . Serum OPG in Chinese men increased with age , and after 70 years increased rapidly .

  2. 骨保护素的克隆及对骨髓间充质干细胞分化的影响

    The clone of OPG and its effects on the differentiation of bome morrow stem cells

  3. 重叠延伸PCR法在合成人骨保护素N端编码序列中的应用

    Amplification of DNA sequence Encoding N-terminal Fragment of Osteoprotegerin Using Overlap-extension PCR

  4. 人骨保护素N端片段在大肠杆菌中的表达及其活性分析

    Expression of N-terminal Fragment of Osteoprotegerin in E.coli Using a New Strategy and Its Bioactivity Characterization

  5. 颌间牵引力对成年大鼠髁状突核因子κB受体活化因子配基/骨保护素的调控

    Regulation of adult rat condyle receptor activator of nuclear factor kappa B ligand / osteoprotegerin by intermaxillary traction force

  6. 骨保护素及双源CT在诊断川崎病并冠状动脉损害的应用

    The Clinical Evaluation of Serum Osteoprotegerin and Dual-source Computed Tomography in Diagnosis of Coronary Artery Lesions in Kawasaki Disease

  7. 人骨保护素cDNA的克隆与表达

    Cloning and Expression of cDNA Sequence Encoding Human Osteoprotegerin

  8. 机械应力影响鼠骨髓基质细胞骨保护素/NF-κB受体活化剂配体mRNA表达变化

    The Effect of Physiological Mechanical Strain upon Osteoprotegerin / Receptor Activator of NF - κ B Ligand mRNA Expression by Murine Stromal Cells

  9. 人骨保护素(OPG)重组腺病毒的制备及其生物活性研究

    Construction and Biological Activity Study of Human Osteoprotegerin Expressing Adenoviral System

  10. 骨保护素OPG在2型糖尿病患者中明显升高。

    Bone protection element OPG in type 2 diabetic patients significantly increased than the controls .

  11. 目的比较幼年鼠和成年鼠牙周组织骨保护素(Osteoprotegerin,OPG)信使RNA(mRNA)表达的不同,以探讨增龄因素影响牙周组织改建的分子机制。

    Objective To investigate the molecular mechanism of age-related effects on periodontal tissue turnover , we examined osteoprotegerin ( OPG ) mRNA expression in young and aged rat periodontal tissues .

  12. 目的为了观察糖皮质激素(GC)短期治疗亚急性甲状腺炎(亚甲炎)患者前后血清骨保护素(OPG)的变化和阿仑膦酸钠(ALN)的骨保护作用。

    Objective To study the changes of serum osteoprotegerin ( OPG ) in patients with subacute thyroiditis ( SAT ) undergoing glucocorticoid therapy and clarify the roles of alendronate in inhibiting bone resorption .

  13. 目的:研究人牙囊细胞白细胞介素-10(IL-10)蛋白的表达及其对骨保护素(osteoprotegerin,OPG)表达的影响。

    Objective : To study the expression of IL-10 at protein level in human dental follicle cells ( HDFCs ) and the effect of IL-10 on osteoprotegerin ( OPG ) secretion .

  14. 目的构建人骨保护素(OPG)哺乳类表达载体并在非洲绿猴肾COS7细胞内初步表达。

    [ Objective ] To construct the mammalia vector of the human osteoprotegerin ( OPG ) and express it primarily in COS 7 cell .

  15. 骨保护素(osteoprotegerin,OPG;又称为OCIF)是肿瘤坏死因子家族成员,对破骨细胞生理性骨吸收起着关键的调控作用。

    Osteoprotegerin ( OPG ) is also a new member of TNF receptor family which plays a key role in the physiological regulation of osteoclastic bone resorption .

  16. 目的:观察骨保护素(osteoprotegerin,OPG)在假体周围各区的浓度变化,研究各区OPG表达与磨损微粒聚积之间的关系。

    Objective : To observe the concentration of osteoprotegerin ( OPG ) around the prostheses , and study the relationship between the concentration of OPG and the accumulation of wear debris .

  17. 肿瘤坏死因子家族成员骨保护素配体(osteoprotegerinligand,OPGL;又称TRANCE,RANKL,ODF)是近年发现的在动物的骨、血液及免疫系统等处分布的,促进破骨细胞分化的蛋白分子。

    The rumor-necrosis-factor-family molecule osteoprotegerin ligand ( OPGL ; also known as TRANCE , RANKL and ODF ) has been lately identified as a potential osteoclast differentiation factor that distributes in bone , blood and immune system .

  18. 骨保护素(OPG)是生理性的抑制破骨细胞性骨吸收的因子,而骨保护素配体(OPGL)是能直接诱导破骨细胞分化发育并参与破骨细胞功能调节的细胞因子。

    Osteoprotegerin ( OPG ) is a physiological cytokine inhibiting bone resorption resulting from osteoclast , while Osteoprotegerin ligand ( OPGL ) is a cytokine which can directly induce osteoclast differentiation and development as well as mediate function regulation of osteoclast .

  19. 假体周围骨保护素表达与磨损微粒分布的关系

    The relation between the concertration of OPG and wear debris accumulation

  20. 骨保护素与去卵巢大鼠骨质疏松模型实验研究

    Experimental Study of the Osteoprotegerin and the Ovariectomized Rat Model of Osteoporosis

  21. 类风湿关节炎患者血清骨保护素水平及临床意义探讨

    Clinical significance of osteoprotegerin level in patients with rheumatoid arthritis

  22. 联合应用骨保护素和阿伦膦酸钠对破骨前体细胞分化的影响

    Effects of combination of bone protectin and alendronate on differentiation of osteoclast precursors

  23. 骨保护素基因修饰的大鼠骨髓基质细胞系的培养、表达与鉴定

    The Culture and Identification of Rat MSC Cell Lines Modified by Osteoprotegerin Gene

  24. 骨保护素配体在燃煤型氟中毒大鼠骨组织中的表达

    Expression of osteoprotegerin ligand in bones of fluorosis rats caused by coal burning

  25. 血清骨保护素在肺癌诊断中的临床价值

    The clinical value of serum osteoprotegerin level in the diagnosis of lung cancer

  26. 骨保护素系统在血管疾病中的研究进展

    Progress in Research of Osteoprotegerin System in Vascular Diseases

  27. 在朗格汉斯细胞组织细胞增生症患儿血清诱饵受体骨保护素水平升高

    Elevated serum levels of the decoy receptor osteoprotegerin in children with Langerhans cell histiocytosis

  28. 雌激素干预对人牙周膜细胞增殖及骨保护素表达的作用

    Effects of estrogen interference on proliferation of human periodontal ligament cells and osteoprotegerin expression

  29. 截短型人骨保护素哺乳类载体的构建、优化及表达

    Construction , Optimization and Expression of Mammalia Recombinant Vector for Truncated Fragment of Human Osteoprotegerin

  30. 局部应用骨保护素对鼠正畸牙移动影响的实验研究

    A study on effects of partial application of osteoprotegerin to orthodontic teeth movement in rats